🇺🇸 FDA
Patent

US 8076343

Benzimidazoles useful as inhibitors of protein kinases

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8076343 (Benzimidazoles useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00